FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Cheer mom, daughter dead in apparent murder-suicide after years-long custody fight: docs

Five injured, including firefighter, in church explosion following reported gas leak in upstate New York

NBC News Buries Background of Latest Trans Mass Shooting Suspect – He ‘Also Went by the First Name Roberta’

Obama dragged for ‘headache’-inducing presidential center update that has visitors squinting

Minnesota Democrats demand reparations from ICE after losing $18 billion to Somali fraud

Dems Try to Cancel Republican Congressman After He Declares Americans Will Not Give Up Dogs to Appease NYC’s Muslims

Hamas dismisses Israel threat to ‘complete the mission’ if terrorist group doesn’t disarm

Mainstream liberals join Soros in bankrolling group backing DC jury nullification effort

Trump hammers AOC Munich stumbles as ‘not a good look for the United States’

Election integrity groups press Supreme Court to require ballots by Election Day

Alert: Hillary Just Signaled a Massive Narrative Change on Immigration – Remember How They Tried to Steal ‘No Tax on Tips’ From Trump? They’re About to Try the Same Move Again

BREAKING: Trans Bombshell in Hockey Shooting – Murderer Robert Dorgan Went by ‘Roberta,’ – This as Reports Killer Wore Women’s Clothing Already Circulating

Georgia father on trial, accused of giving son rifle before school shooting

Rhode Island ice rink shooting suspect’s gender identity was source of past family conflict: docs

House Dem’s graphic chicken decapitation ‘horrified’ her college roommates: ‘Blood went everywhere’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”